Interferon alfa-2b in patients with low-grade lymphomatoid granulomatosis and chemotherapy with DA-EPOCH-R in patients with high-grade lymphomatoid granulomatosis: an open-label, single-centre, phase 2 trial https://t.co/NIL3FJdCK0
3,597 followers
94 followers
Study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis https://t.co/HL1tuDAzyE https://t.co/PEJuAEvnUs https://t.co/puI9AC8zNB
1,163 followers
40 followers
RT @TheLancetHaem: NEW online: a phase 2 trial @theNCI investigated the activity and safety of interferon alfa-2b immunotherapy in patients…